Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 159 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Amylyx Pharmaceuticals Inc | AMLX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.71 | 03:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.71 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 2 | 159 | - | 1.65 - 26.44 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 03:06:36 | 1 | US$ 1.73 | USD |
Amylyx Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 115.91M | 67.78M | - | 380.79M | 49.27M | 0.73 | 2.35 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Amylyx Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMLX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.71 | 1.78 | 1.65 | 1.70 | 1,451,570 | 0.00 | 0.00% |
| 1 Month | 1.96 | 1.9922 | 1.65 | 1.79 | 1,365,636 | -0.25 | -12.76% |
| 3 Months | 3.44 | 3.50 | 1.65 | 2.33 | 2,112,466 | -1.73 | -50.29% |
| 6 Months | 14.47 | 19.9488 | 1.65 | 6.49 | 2,316,863 | -12.76 | -88.18% |
| 1 Year | 25.20 | 26.44 | 1.65 | 10.99 | 1,824,083 | -23.49 | -93.21% |
| 3 Years | 21.00 | 41.9297 | 1.65 | 17.60 | 1,327,288 | -19.29 | -91.86% |
| 5 Years | 21.00 | 41.9297 | 1.65 | 17.60 | 1,327,288 | -19.29 | -91.86% |
Amylyx Pharmaceuticals Description
| Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. |
